{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:34:59Z","timestamp":1779399299018,"version":"3.53.1"},"reference-count":28,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:p>The need for sedation and analgesia and treatment of iatrogenic drug withdrawal is common in critically ill children. First\u2010line therapy typically includes opioid agonists. However, clonidine, a central \u03b1<jats:sub>2<\/jats:sub> agonist, has been suggested as a treatment option for sedation and analgesia and iatrogenic drug withdrawal. Therefore, we conducted a literature search to identify articles evaluating the use of enteral (PO) and transdermal clonidine in critically ill infants and children for sedation and analgesia and treatment of iatrogenic drug withdrawal. The literature search was limited to English\u2010language articles in Medline (1946\u2013May 2016), Embase (1988\u2013May 2016), and <jats:italic>International Pharmaceutical Abstracts<\/jats:italic> (1970\u2013May 2016). Reference citations from relevant articles were also reviewed. Ten case reports and studies, representing a total of 114 children receiving clonidine, were included. Fifty patients (43.9%) received clonidine for sedation and analgesia while mechanically ventilated, and 33 (29.0%) received clonidine for treatment or prevention of drug withdrawal. The remaining 31 patients (27.1%) were included in a pharmacokinetic study that did not evaluate clinical outcomes. Seventy\u2010nine patients (69.3%) received PO clonidine, with a dosage range of 2\u201315 \u00b5g\/kg\/day divided every 6\u20138 hours. Thirty\u2010five patients (30.7%) received transdermal clonidine, with a dosage range of 2.3\u201320 \u00b5g\/kg\/day. Whole, cut, and occluded transdermal patches were used in the reports. Patients receiving cut patches had more variable and significantly higher serum clonidine concentrations than those receiving whole patches. Only three studies reported that the PO clonidine dose was tapered at the end of therapy; however, no report specifically described the process. The two most common adverse events reported with PO and transdermal clonidine were bradycardia and hypotension. PO and transdermal clonidine have a potential role for sedation and analgesia and drug withdrawal in critically ill infants and children. The use of cut transdermal patches should be avoided. Future prospective studies are needed to further define clonidine's role as adjunct therapy or monotherapy.<\/jats:p>","DOI":"10.1002\/phar.1850","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T11:17:04Z","timestamp":1477394224000},"page":"1290-1299","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children"],"prefix":"10.1002","volume":"36","author":[{"given":"Amanda C.","family":"Capino","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice University of Mississippi School of Pharmacy Jackson Mississippi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pharmacy: Clinical and Administrative Sciences University of Oklahoma College of Pharmacy Oklahoma City Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy: Clinical and Administrative Sciences University of Oklahoma College of Pharmacy Oklahoma City Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90744-3"},{"key":"e_1_2_6_3_1","volume-title":"Pediatric and neonatal dosage handbook","author":"Taketomo CK","year":"2015"},{"key":"e_1_2_6_4_1","first-page":"270","article-title":"Clonidine in paediatrics: a review","volume":"53","author":"Basker S","year":"2009","journal-title":"Indian J Anaesth"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-0489"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2008.02413.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000151"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-004-2319-0"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeu258"},{"key":"e_1_2_6_10_1","first-page":"43","article-title":"Plasma concentrations following application of whole versus cut transdermal clonidine patches to critically ill children","volume":"9","author":"Zuppa AF","year":"2004","journal-title":"J Pediatr Pharmacol Ther"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010370587"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013514026"},{"key":"e_1_2_6_13_1","first-page":"CD002052","article-title":"Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit","volume":"1","author":"Ng E","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199708000-00025"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e318253c80e"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2004.01515.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2014.05.029"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1996.01890230080015"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/0885066607299556"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650902980019"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2011.03630.x"},{"key":"e_1_2_6_22_1","first-page":"45","article-title":"Effects of clonidine on withdrawal from long\u2010term dexmedetomidine in the pediatric patient","volume":"20","author":"Lardieri AB","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1997.tb04703.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015626438"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1542\/pir.34-6-258"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2005.00733_1.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1891\/0730-0832.19.6.67"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.10.003"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015620625"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fphar.1850","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fphar.1850","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.1850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:06:43Z","timestamp":1761048403000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.1850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1002\/phar.1850"],"URL":"https:\/\/doi.org\/10.1002\/phar.1850","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,25]]},"assertion":[{"value":"2016-11-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}